DNA polymerase delta subunit 4 (POLD4, also known as p12) is the smallest accessory subunit of the tetrameric DNA polymerase delta complex, which is a major eukaryotic DNA polymerase required for high-fidelity DNA replication and repair. POLD4 enhances the rate of DNA synthesis and modulates the proofreading activity of the complex by regulating the main catalytic subunit (POLD1). Under replication stress or DNA damage, POLD4 can be degraded, altering the polymerase composition and activity to favor repair and cell survival. POLD4 is implicated in several DNA repair pathways (e.g., base excision repair, Okazaki fragment processing, translesion synthesis), and plays a structural and functional role in maintaining genome stability in dividing cells.
Indirectly, drugs targeting DNA replication may impair DNA polymerase delta activity, often by incorporation of nucleotide analogs or causing DNA damage. Any hypothetical direct POLD4-targeted drug would likely affect DNA replication fidelity, repair, or processivity.
03
Biological functions
DNA replicationDNA repair (e.g., base excision repair, Okazaki fragment processing)Replicative fidelity and proofreading (regulates both polymerase and exonuclease activity)DNA synthesis at replication forks; role in replication fork repair and stabilization through interaction with Bloom syndrome proteinParticipates in translesion synthesis (TLS), especially under DNA damage stress
04
Disease associations
Cancer (due to its essential role in genome stability and replication fidelity)Xeroderma pigmentosum group G (from associated gene variant)Genomic instability disorders (via defective DNA repair or replication)Other diseases involving impaired DNA repair, genome duplication, and mutagenesis
05
Safety considerations
Essential for cell viability: inhibition or dysfunction leads to replication failure, genome instability, and cell deathPotential mutagenesis: if fidelity is compromised, this could increase cancer risk or disease severityToxicity/challenge in targeting: as a housekeeping replication factor, systemic inhibition presents narrow therapeutic windows and off-target toxicity
Beyond the preview
Go deeper on DNA polymerase delta subunit 4 (POLD4).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on DNA polymerase delta subunit 4 (POLD4).